RE: The Duplicitous Piglet - CV update23 Oct 2024 09:48
@Paternostpauper
You can try and be as insulting as you like to try and detract from the pump going on here designed to uplift the SP to be sold into for the placing.
Seen it so many times now it’s beyond ridiculous, just dam sad that there will be inexperienced RI that could get taken in by the BS here who don’t know how the game is played - shame on you for playing a part in that, it is Not OK.
As for your insinuation that I post as Share4 you are way off the mark, just because that poster doesn’t buy the BS in these threads either doesn’t make us one of the same.
The reality here, back on topic, is i suspect that they are now running on fumes, the placing is now essential so the real question is can they sucker support for raise 15 or not?
Meanwhile you will no doubt carry on ramping BUT I fear your energy wasted, market outlook has changed, biotech investment landscape changed, smart money and licensing deals only going into truly exceptional innovations, prevention, vaccine developments and the like and the investment outlook still very challenging. On top of that small retail investors will likely get hit with CGT increases in next weeks budget making AIM even less attractive so to say ME has his work cut out against that backdrop is understatement of the year!
But let’s see how events unfold shall we, you know it and I know it.